Document is current
Any future updates will be listed below
-
Authors
Roosen, Joey https://orcid.org/0000-0002-7965-6664
Westlund Gotby, Lovisa E. L. https://orcid.org/0000-0002-1059-6616
Arntz, Mark J. https://orcid.org/0000-0002-2402-7617
Fütterer, Jurgen J. https://orcid.org/0000-0001-6800-2879
Janssen, Marcel J. R.
Konijnenberg, Mark W. https://orcid.org/0000-0001-5895-8500
van Wijk, Meike W. M. https://orcid.org/0000-0002-4626-6694
Overduin, Christiaan G. https://orcid.org/0000-0002-4589-4357
Nijsen, J. Frank W. https://orcid.org/0000-0001-7625-2253
-
Funding
Funding for this research was provided by:
European Fund for Regional Development
- License Information
-
More Information
Article History
Received: 9 March 2022
Accepted: 30 June 2022
First Online: 13 July 2022
Declarations
:
: J. F. W. Nijsen is a co-founder of Quirem Medical which has been acquired by Terumo Europe NV in July 2020. Nijsen has a scientific advisory role and is entitled to certain milestone payments from Terumo which are related to Quirem’s financial, operational and regulatory performance in the future. Furthermore, Nijsen is an inventor on the patents related to radioactive microspheres that are assigned to University Medical Center Utrecht Holding BV, Quirem Medical or BASF Corp. The activities of J. F. W. Nijsen within Quirem Medical are approved and supported by the Board of Directors of the Radboudumc. The other authors declare that they have no conflict of interest.
